-
-
7 . Periodical
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
- 저자
- by Ramacciotti, Eduardo; Barile Agati, Leandro; Calderaro, Daniela; Aguiar, Valéria Cristina Resende; Spyropoulos, Alex C, et al.
- 소스
- The Lancet; January 2022, Vol. 399 Issue: 10319 p50-59, 10p